CRBP - What's Going On With Cancer-Focused Corbus Pharmaceuticals Stock Today? | Benzinga
Wednesday, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) priced an underwritten public offering of 4.325 million shares at $19.00 per share to raise approximately $82.2 million in gross proceeds.
In addition, Corbus granted the underwriters a 30-day option to purchase up to an additional 648,750 shares.
Corbus will use the net proceeds of the offering to fund the clinical development of its pipeline and ...